Immune disorders are associated with non-classical NF-KB pathway dysfunction, and expression of NF-κB-inducing kinase (NIK) is the rate-limiting step in non-canonical NF-κB activation [176, 177]. This evidence concerns the gene NFKB1 and immune system disorder.